Articles by Melissa Badamo
Studies have shown that oncologists are leaving the workforce at increasing rates in association with growing workloads.
This issue includes a feature on diet and multiple myeloma risk, a Get to Know with Kerry Rogers, MD, and more.
Dr. Rogers shares her career trajectory, what being a doctor is about, and a glimpse of her pet guinea pigs, Maple and Brady.
Non-Hispanic Black women had the highest odds for hypertensive disorders of pregnancy, preterm birth, and fetal death.
Tuspetinib in combination with venetoclax and azacitidine showed promising clinical safety and antileukemic activity in AML.
Experts discuss the link between dietary patterns and blood cancer risk and the shortcomings of epidemiological studies.
Charles Gaulin, MBBS, discussed the future of lymphoma treatment, including the development of novel cellular therapies.
LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, and more..
Dr. Locke is a lead investigator of the ZUMA-1 and ZUMA-7 trials, which led to the FDA approval of axi-cel.
Charles Gaulin, MBBS, discussed the safety and efficacy of CD19 CAR-T cell therapy for transformed indolent lymphoma.
A pooled analysis of four randomized controlled trials found that statin use was associated with improved OS and PFS.
The awards recognize early-, mid-, or senior-career experts who display excellence in the field.
Mice treated with CLK3 TCR9-T cells had a significantly lower tumor burden than those who received control treatments.
CR1-02 was well-tolerated and led to stable disease in patients with relapsed or refractory AML.
William Morice, MD, PhD, President and CEO of Mayo Clinic Laboratories, discussed a collaboration to expand cancer testing.
The Community Oncology Alliance outlined solutions for Congress to address systemic challenges of the U.S. healthcare system.
This issue includes a feature on government funding, an editor's letter by Mehdi H. Hamadani, MD, and more.
Dr. Parekh discussed the promising future of trispecifics, the group of patients with the largest unmet need, and more.
Gaurav Goyal, MD, spoke to Blood Cancers Today about strategies and guidelines for incorporating PROs into clinical trials.
Samir Parekh, MD, Appointed Director of the Center of Excellence for Multiple Myeloma at Mount Sinai
Dr. Parekh’s laboratory focuses on developing personalized treatment strategies for patients with multiple myeloma.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.